These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 14505276)

  • 21. From the Centers for Disease Control and Prevention. Update: investigation of bioterrorism-related inhalation anthrax--Connecticut, 2001.
    JAMA; 2001 Dec; 286(23):2936-7. PubMed ID: 11787482
    [No Abstract]   [Full Text] [Related]  

  • 22. Update: Investigation of bioterrorism-related anthrax and interim guidelines for clinical evaluation of persons with possible anthrax.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Nov; 50(43):941-8. PubMed ID: 11708591
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human anthrax as a re-emerging disease.
    Doganay M; Demiraslan H
    Recent Pat Antiinfect Drug Discov; 2015; 10(1):10-29. PubMed ID: 25851429
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anthrax: ENT manifestations and current concepts.
    Wirtschafter A; Cherukuri S; Benninger MS
    Otolaryngol Head Neck Surg; 2002 Jan; 126(1):8-13. PubMed ID: 11821758
    [TBL] [Abstract][Full Text] [Related]  

  • 25. No evidence of a mild form of inhalational Bacillus anthracis infection during a bioterrorism-related inhalational anthrax outbreak in Washington, D.C., in 2001.
    Baggett HC; Rhodes JC; Fridkin SK; Quinn CP; Hageman JC; Friedman CR; Dykewicz CA; Semenova VA; Romero-Steiner S; Elie CM; Jernigan JA
    Clin Infect Dis; 2005 Oct; 41(7):991-7. PubMed ID: 16142664
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bioterrorism. Researchers question obsession with Cipro.
    Enserink M
    Science; 2001 Oct; 294(5543):759-61. PubMed ID: 11679638
    [No Abstract]   [Full Text] [Related]  

  • 27. Epidemiologic investigations of bioterrorism-related anthrax, New Jersey, 2001.
    Greene CM; Reefhuis J; Tan C; Fiore AE; Goldstein S; Beach MJ; Redd SC; Valiante D; Burr G; Buehler J; Pinner RW; Bresnitz E; Bell BP;
    Emerg Infect Dis; 2002 Oct; 8(10):1048-55. PubMed ID: 12396914
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Update: Investigation of bioterrorism-related anthrax--Connecticut, 2001.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Dec; 50(48):1077-9. PubMed ID: 11770501
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical predictors of bioterrorism-related inhalational anthrax.
    Tepper M; Whitehead J
    Lancet; 2005 Jan 15-21; 365(9455):214; author reply 215. PubMed ID: 15652600
    [No Abstract]   [Full Text] [Related]  

  • 30. More on anthrax exposure case report.
    McFee RB; Howell JT
    J Am Osteopath Assoc; 2002 Jul; 102(7):362-3; author reply 363-4. PubMed ID: 12138949
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinical predictors of bioterrorism-related inhalational anthrax.
    Gair R
    Lancet; 2005 Jan 15-21; 365(9455):214-5; author reply 215. PubMed ID: 15652599
    [No Abstract]   [Full Text] [Related]  

  • 32. Pathology and pathogenesis of bioterrorism-related inhalational anthrax.
    Guarner J; Jernigan JA; Shieh WJ; Tatti K; Flannagan LM; Stephens DS; Popovic T; Ashford DA; Perkins BA; Zaki SR;
    Am J Pathol; 2003 Aug; 163(2):701-9. PubMed ID: 12875989
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anthrax infection.
    Sweeney DA; Hicks CW; Cui X; Li Y; Eichacker PQ
    Am J Respir Crit Care Med; 2011 Dec; 184(12):1333-41. PubMed ID: 21852539
    [TBL] [Abstract][Full Text] [Related]  

  • 34. From the Centers for Disease Control and Prevention. Update: Investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001.
    JAMA; 2001 Nov; 286(18):2226-32. PubMed ID: 11757528
    [No Abstract]   [Full Text] [Related]  

  • 35. Inhalational anthrax after bioterrorism exposure: spectrum of imaging findings in two surviving patients.
    Earls JP; Cerva D; Berman E; Rosenthal J; Fatteh N; Wolfe PP; Clayton R; Murphy C; Pauze D; Mayer T; Bersoff-Matcha S; Urban B
    Radiology; 2002 Feb; 222(2):305-12. PubMed ID: 11818592
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhalational anthrax outbreak among postal workers, Washington, D.C., 2001.
    Dewan PK; Fry AM; Laserson K; Tierney BC; Quinn CP; Hayslett JA; Broyles LN; Shane A; Winthrop KL; Walks I; Siegel L; Hales T; Semenova VA; Romero-Steiner S; Elie C; Khabbaz R; Khan AS; Hajjeh RA; Schuchat A;
    Emerg Infect Dis; 2002 Oct; 8(10):1066-72. PubMed ID: 12396917
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cutaneous anthrax: an overview.
    Celia F
    Dermatol Nurs; 2002 Apr; 14(2):89-92. PubMed ID: 12017087
    [TBL] [Abstract][Full Text] [Related]  

  • 38. From the Centers for Disease Control and Prevention. Investigation of bioterrorism-related anthrax and interim guidelines for clinical evaluation of persons with possible anthrax.
    Centers for Disease Control and Prevention
    JAMA; 2001 Nov; 286(19):2392-6. PubMed ID: 11759667
    [No Abstract]   [Full Text] [Related]  

  • 39. Historical evolution of human anthrax from occupational disease to potentially global threat as bioweapon.
    D'Amelio E; Gentile B; Lista F; D'Amelio R
    Environ Int; 2015 Dec; 85():133-46. PubMed ID: 26386727
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Zoonosis update. Anthrax.
    Shadomy SV; Smith TL
    J Am Vet Med Assoc; 2008 Jul; 233(1):63-72. PubMed ID: 18593313
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.